An Open Label Extension Study in Subjects With Fragile X Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Wang, M.D.
Seaside Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Seaside Therapeutics Site #16
Phoenix, Arizona, United States
- Seaside Therapeutics Site #07
Long Beach, California, United States
- Seaside Therapeutics Site #10
Sacramento, California, United States
- Seaside Therapeutics Site #17
Aurora, Colorado, United States
- Seaside Therapeutics Site #01
Miami, Florida, United States
- Seaside Therapeutics Site #14
Orange City, Florida, United States
- Seaside Therapeutics Site #20
Decatur, Georgia, United States
- Seaside Therapeutics Site #02
Chicago, Illinois, United States
- Seaside Therapeutics Site #23
Kansas City, Kansas, United States
- Seaside Therapeutics Site #12
Baltimore, Maryland, United States
- Seaside Therapeutics Site #08
Worcester, Massachusetts, United States
- Seaside Therapeutics Site #03
Columbia, Missouri, United States
- Seaside Therapeutics Site #22
New York, New York, United States
- Seaside Therapeutics Site #04
Staten Island, New York, United States
- Seaside Therapeutics Site #24
Chapel Hill, North Carolina, United States
- Seaside Therapeutics Site #21
Durham, North Carolina, United States
- Seaside Therapeutics Site #05
Akron, Ohio, United States
- Seaside Therapeutics Site #15
Oklahoma City, Oklahoma, United States
- Seaside Therapeutics Site #11
Media, Pennsylvania, United States
- Seaside Therapeutics Site #19
Nashville, Tennessee, United States
- Seaside Therapeutics Site #25
Houston, Texas, United States
- Seaside Therapeutics Site #18
San Antonio, Texas, United States
- Seaside Therapeutics Site #13
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2011
- Primary completion
- 31 Jul 2013
- Completion
- 31 Jul 2013
- Last update posted
- 31 Jul 2013
- Registered enrollment
- 357
- Registry id
- NCT01555333
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.